FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gabriel Virella

Research Profile

Chemicals & Drugs

Procedures

Anatomy

Disorders

Living Beings

Rabbits

Physiology

Antibody Formation

Co-author Network

Publications

TOP 3
Gabriel Virella; Nathaniel L Baker; Charlyne Chassereau; Joan Colglazier; Kelly J Hunt; Maria F Lopes-Virella
Immunoassay of modified forms of human low density lipoprotein in isolated circulating immune complexes.
Maria F Lopes-Virella; Thomas Moritz; Gabriel Virella; Nathaniel L Baker; Kelly J Hunt
The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study.
Maria F Lopes-Virella; Timothy J Lyons; Gabriel Virella; Nathaniel L Baker; Kelly J Hunt; Alicia J Jenkins
High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gabriel Virella (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Gabriel Virella; Nathaniel L Baker; Charlyne Chassereau; Joan Colglazier; Kelly J Hunt; Maria F Lopes-Virella
Immunoassay of modified forms of human low density lipoprotein in isolated circulating immune complexes.
Journal of immunoassay & immunochemistry 2013;34(1):61-74.
2012: Maria F Lopes-Virella; Thomas Moritz; Gabriel Virella; Nathaniel L Baker; Kelly J Hunt
The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study.
Atherosclerosis 2012;224(2):526-31.
2012: Maria F Lopes-Virella; Timothy J Lyons; Gabriel Virella; Nathaniel L Baker; Kelly J Hunt; Alicia J Jenkins
High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes.
Diabetes care 2012;35(6):1333-40.
2012: Jean-Philip Truman; Gabriel Virella; Mohammed M Al Gadban; Alicja Bielawska; Yusuf A Hannun; Russell W Jenkins; Maria F Lopes-Virella; Nalini Mayroo; Kent J Smith; Samar M Hammad
Differential regulation of acid sphingomyelinase in macrophages stimulated with oxidized low-density lipoprotein (LDL) and oxidized LDL immune complexes: role in phagocytosis and cytokine release.
Immunology 2012;136(1):30-45.
2012: Maria F Lopes-Virella; Gabriel Virella; Nathaniel L Baker; Rickey E Carter; John Lachin
High levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetes.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012;27(4):1416-23.
2012: Gabriel Virella; Maria F Lopes-Virella
The Pathogenic Role of the Adaptive Immune Response to Modified LDL in Diabetes.
Frontiers in endocrinology 2012;3():76.
2011: Souzan A Abdelsamie; Yanchun Li; Yan Huang; Mi-Hye Lee; Richard L Klein; Gabriel Virella; Maria F Lopes-Virella
Oxidized LDL immune complexes stimulate collagen IV production in mesangial cells via Fc gamma receptors I and III.
Clinical immunology (Orlando, Fla.) 2011;139(3):258-66.
2011: Richard L Klein; Rickey E Carter; Alicia J Jenkins; Timothy J Lyons; Nathaniel L Baker; Gregory Gilbert; Gabriel Virella; Maria F Lopes-Virella
LDL-containing immune complexes in the DCCT/EDIC cohort: associations with lipoprotein subclasses.
Journal of diabetes and its complications 2011;25(2):73-82.
2011: Maria F Lopes-Virella; Nathaniel L Baker; Kelly J Hunt; John Lachin; David Nathan; Gabriel Virella
Oxidized LDL immune complexes and coronary artery calcification in type 1 diabetes.
Atherosclerosis 2011;214(2):462-7.
2011: Maria F Lopes-Virella; Kelly J Hunt; Nathaniel L Baker; John Lachin; David M Nathan; Gabriel Virella
Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes.
Diabetes 2011;60(2):582-9.
2010: Kent J Smith; Waleed O Twal; Farzan Soodavar; Gabriel Virella; Maria F Lopes-Virella; Samar M Hammad
Heat shock protein 70B' (HSP70B') expression and release in response to human oxidized low density lipoprotein immune complexes in macrophages.
The Journal of biological chemistry 2010;285(21):15985-93.
2010: Mohammed M Al Gadban; Kent J Smith; Farzan Soodavar; Christabelle Piansay; Charlyne Chassereau; Waleed O Twal; Richard L Klein; Gabriel Virella; Maria F Lopes-Virella; Samar M Hammad
Differential trafficking of oxidized LDL and oxidized LDL immune complexes in macrophages: impact on oxidative stress.
PloS one 2010;5(9):.
2010: Gabriel Virella
Immunology of cardiovascular disease.
Clinical immunology (Orlando, Fla.) 2010;134(1):1-4.
2010: Maria F Lopes-Virella; Gabriel Virella
Clinical significance of the humoral immune response to modified LDL.
Clinical immunology (Orlando, Fla.) 2010;134(1):55-65.
2009: Samar M Hammad; Waleed O Twal; Jeremy L Barth; Kent J Smith; Antonio F Saad; Gabriel Virella; Scott Argraves; Maria F Lopes-Virella
Oxidized LDL immune complexes and oxidized LDL differentially affect the expression of genes involved with inflammation and survival in human U937 monocytic cells.
Atherosclerosis 2009;202(2):394-404.
2008: Maria F Lopes-Virella; Rickey Carter; Gregory Gilbert; Richard L Klein; Miran Jaffa; Alicia J Jenkins; Timothy J Lyons; W Timothy Garvey; Gabriel Virella
Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications.
Diabetes care 2008;31(10):2006-12.
2008: Gabriel Virella; Maria F Lopes-Virella
Atherogenesis and the humoral immune response to modified lipoproteins.
Atherosclerosis 2008;200(2):239-46.
2008: Gabriel Virella; Rickey Carter; Antonio Saad; Edward G Crosswell; Bryan A Game; Maria F Lopes-Virella
Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathy.
Clinical immunology (Orlando, Fla.) 2008;127(3):394-400.
2007: Maria F Lopes-Virella; M Brent McHenry; Stuart R Lipsitz; Eunsil Yim; Peter F Wilson; Daniel T Lackland; Timothy Lyons; Alicia J Jenkins; Gabriel Virella
Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes.
Atherosclerosis 2007;190(2):359-69.
2006: Antonio F Saad; Gabriel Virella; Charlyne Chassereau; Robert J Boackle; Maria F Lopes-Virella
OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages.
Journal of lipid research 2006;47(9):1975-83.
2006: Aklilu A Yishak; Tina Costacou; Gabriel Virella; Janice C Zgibor; Linda Fried; Michael Walsh; Rhobert W Evans; Maria F Lopes-Virella; Valerian E Kagan; James D Otvos; Trevor J Orchard
Novel predictors of overt nephropathy in subjects with type 1 diabetes. A nested case control study from the Pittsburgh Epidemiology of Diabetes Complications cohort.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(1):93-100.
2005: Tina Costacou; Maria F Lopes-Virella; Janice C Zgibor; Gabriel Virella; James D Otvos; Michael Walsh; Trevor J Orchard
Markers of endothelial dysfunction in the prediction of coronary artery disease in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.
Journal of diabetes and its complications 2005;19(4):183-93.
2005: Maria F Lopes-Virella; Suzanne R Thorpe; M Brooks Derrick; Charlyne Chassereau; Gabriel Virella
The immunogenicity of modified lipoproteins.
Annals of the New York Academy of Sciences 2005;1043():367-78.
2005: William Cassidy; Glenn Jones; Karen Williams; Adamadia Deforest; Bagher Forghani; Gabriel Virella; Charmaine Venters
Safety and immunogenicity of concomitant versus nonconcomitant administration of hepatitis B, tetanus-diphtheria, and measles-mumps-rubella vaccines in healthy eleven- to twelve-year-olds.
The Journal of adolescent health : official publication of the Society for Adolescent Medicine 2005;36(3):187-92.
2005: Gabriel Virella; M Brooks Derrick; Virginia Pate; Charlyne Chassereau; Suzanne R Thorpe; Maria F Lopes-Virella
Development of capture assays for different modifications of human low-density lipoprotein.
Clinical and diagnostic laboratory immunology 2005;12(1):68-75.
2004: Gabriel Virella; Suzanne R Thorpe; Nathan L Alderson; M Brooks Derrick; Charlyne Chassereau; J Matthew Rhett; Maria F Lopes-Virella
Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodies.
Journal of lipid research 2004;45(10):1859-67.
2004: Maria F Lopes-Virella; Marina Mironova; Elias Stephan; Ramon Durazo-Arvizu; Gabriel Virella
Role of simvastatin as an immunomodulator in type 2 diabetes.
Diabetes care 2004;27(4):908-13.
2003: Maria F Lopes-Virella; Gabriel Virella
The role of immune and inflammatory processes in the development of macrovascular disease in diabetes.
Frontiers in bioscience : a journal and virtual library 2003;8():s750-68.
2003: Gabriel Virella; Maria F Lopes-Virella
Lipoprotein autoantibodies: measurement and significance.
Clinical and diagnostic laboratory immunology 2003;10(4):499-505.
2003: Yuchang Fu; Yan Huang; Sumita Bandyopadhyay; Gabriel Virella; Maria F Lopes-Virella
LDL immune complexes stimulate LDL receptor expression in U937 histiocytes via extracellular signal-regulated kinase and AP-1.
Journal of lipid research 2003;44(7):1315-21.
2003: Gabriel Virella; Maria F Lopes-Virella
Humoral immunity and atherosclerosis.
Nature medicine 2003;9(3):243-4; author reply 244-5.
2003: Gabriel Virella; Suzanne R Thorpe; Nathan L Alderson; Elias M Stephan; Daniel Atchley; Francesco Wagner; Maria F Lopes-Virella
Autoimmune response to advanced glycosylation end-products of human LDL.
Journal of lipid research 2003;44(3):487-93.
2002: Daniel Atchley; Maria F Lopes-Virella; D Zheng; D Kenny; Gabriel Virella
Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathy.
Diabetologia 2002;45(11):1562-71.
2002: Gabriel Virella; Daniel Atchley; Sinikka Koskinen; D Zheng; Maria F Lopes-Virella
Proatherogenic and proinflammatory properties of immune complexes prepared with purified human oxLDL antibodies and human oxLDL.
Clinical immunology (Orlando, Fla.) 2002;105(1):81-92.
2002: Silvana A Vielma; Gabriel Virella; Adam Gorod; Maria F Lopes-Virella
Chlamydophila pneumoniae infection of human aortic endothelial cells induces the expression of FC gamma receptor II (FcgammaRII).
Clinical immunology (Orlando, Fla.) 2002;104(3):265-73.
2001: Philip D Hall; Gabriel Virella; T Willoughby; Daniel Atchley; Robert J Kreitman; Arthur E Frankel
Antibody response to DT-GM, a novel fusion toxin consisting of a truncated diphtheria toxin (DT) linked to human granulocyte-macrophage colony stimulating factor (GM), during a phase I trial of patients with relapsed or refractory acute myeloid leukemia.
Clinical immunology (Orlando, Fla.) 2001;100(2):191-7.
2000: Yan Huang; A J Fleming; S Wu; Gabriel Virella; Maria F Lopes-Virella
Fc-gamma receptor cross-linking by immune complexes induces matrix metalloproteinase-1 in U937 cells via mitogen-activated protein kinase.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(12):2533-8.
2000: Maria F Lopes-Virella; Sinikka Koskinen; Marina Mironova; D Horne; Richard L Klein; Charlyne Chassereau; Candace Enockson; Gabriel Virella
The preparation of copper-oxidized LDL for the measurement of oxidized LDL antibodies by EIA.
Atherosclerosis 2000;152(1):107-15.
2000: Marina Mironova; Richard L Klein; Gabriel Virella; Maria F Lopes-Virella
Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes.
Diabetes 2000;49(6):1033-41.
2000: Gabriel Virella; Sinikka Koskinen; Gregor Krings; JM Onorato; Suzanne R Thorpe; Maria F Lopes-Virella
Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies.
Clinical immunology (Orlando, Fla.) 2000;95(2):135-44.
1999: Trevor J Orchard; Gabriel Virella; Kimberly Y Z Forrest; R W Evans; Dorothy J Becker; Maria F Lopes-Virella
Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study.
Diabetes 1999;48(7):1454-8.
1999: R A Weaver; Gabriel Virella; A Weaver
Ehrlichiosis with severe pulmonary manifestations despite early treatment.
Southern medical journal 1999;92(3):336-9.
1999: Maria F Lopes-Virella; Gabriel Virella; T J Orchard; Sinikka Koskinen; R W Evans; D J Becker; K Y Forrest
Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
Clinical immunology (Orlando, Fla.) 1999;90(2):165-72.
1998: Sinikka Koskinen; Candace Enockson; Maria F Lopes-Virella; Gabriel Virella
Preparation of a human standard for determination of the levels of antibodies to oxidatively modified low-density lipoproteins.
Clinical and diagnostic laboratory immunology 1998;5(6):817-22.
1998: Rebecca L Rogers; Tariq Javed; R E Ross; Gabriel Virella; Robert Stuart; Debra Frei-Lahr
Transfusion management of an IgA deficient patient with anti-IgA and incidental correction of IgA deficiency after allogeneic bone marrow transplantation.
American journal of hematology 1998;57(4):326-30.
1997: Maria F Lopes-Virella; N Binzafar; S Rackley; A Takei; M La Via; Gabriel Virella
The uptake of LDL-IC by human macrophages: predominant involvement of the Fc gamma RI receptor.
Atherosclerosis 1997;135(2):161-70.
1997: Marina Mironova; Gabriel Virella; Isabel Virella-Lowell; Maria F Lopes-Virella
Anti-modified LDL antibodies and LDL-containing immune complexes in IDDM patients and healthy controls.
Clinical immunology and immunopathology 1997;85(1):73-82.
1997: Melodie A. Olson; Nancee Sneed; M LaVia; Gabriel Virella; Ramita J Bonadonna; Yvonne Michel
Stress-induced immunosuppression and therapeutic touch.
Alternative therapies in health and medicine 1997;3(2):68-74.
1997: Sarah Hall Gueldner; Leonard W Poon; M La Via; Gabriel Virella; Yvonne Michel; Martha Hains Bramlett; C A Noble; E Paulling
Long-term exercise patterns and immune function in healthy older women. A report of preliminary findings.
Mechanisms of ageing and development 1997;93(1-3):215-22.
1996: Maria F Lopes-Virella; Gabriel Virella
Modified lipoproteins, cytokines and macrovascular disease in non-insulin-dependent diabetes mellitus.
Annals of medicine 1996;28(4):347-54.
1996: Maria F Lopes-Virella; Gabriel Virella
Cytokines, modified lipoproteins, and arteriosclerosis in diabetes.
Diabetes 1996;45 Suppl 3():S40-4.
1996: Maria F Lopes-Virella; Richard L Klein; Gabriel Virella
Modification of lipoproteins in diabetes.
Diabetes/metabolism reviews 1996;12(1):69-90.
1996: Marina Mironova; Gabriel Virella; Maria F Lopes-Virella
Isolation and characterization of human antioxidized LDL autoantibodies.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(2):222-9.
1995: Gabriel Virella; J F Muñoz; G M Galbraith; C Gissinger; C Chassereau; Maria F Lopes-Virella
Activation of human monocyte-derived macrophages by immune complexes containing low-density lipoprotein.
Clinical immunology and immunopathology 1995;75(2):179-89.
1995: Peter J Gergen; Geraldine M McQuillan; M Kiely; T M Ezzati-Rice; R W Sutter; Gabriel Virella
A population-based serologic survey of immunity to tetanus in the United States.
The New England journal of medicine 1995;332(12):761-6.
1995: Gabriel Virella; Marina Mironova; Maria F Lopes-Virella
Comparing assays of antibodies to modified low-density lipoproteins.
Clinical chemistry 1995;41(2):324-5.
1995: J M Hathaway; Russell A Harley; Sally Self; G Schiffman; Gabriel Virella
Immunological function in post-traumatic splenosis.
Clinical immunology and immunopathology 1995;74(2):143-50.
1994: Maria F Lopes-Virella; Gabriel Virella
Atherosclerosis and autoimmunity.
Clinical immunology and immunopathology 1994;73(2):155-67.
1993: Gabriel Virella; Isabel Virella-Lowell; Robert B Leman; M B Pryor; Maria F Lopes-Virella
Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers.
International journal of clinical & laboratory research 1993;23(2):95-101.
1993: Gabriel Virella; A C Wang
Biosynthesis, metabolism and biological properties of immunoglobulins.
Immunology series 1993;58():91-102.
1993: Gabriel Virella; C Patrick; J M Goust
Tissues and cells involved in the immune response.
Immunology series 1993;58():9-27.
1993: Gabriel Virella; A C Wang
Immunoglobulin structure.
Immunology series 1993;58():75-90.
1993: Gabriel Virella
Immunodeficiency diseases.
Immunology series 1993;58():543-77.
1993: Gabriel Virella; J M Goust
Malignancies of the immune system.
Immunology series 1993;58():517-41.
1993: Gabriel Virella; D S Machado; R Galbraith
Transplantation immunology.
Immunology series 1993;58():481-95.
1993: J M Goust; H Stevenson; R Galbraith; Gabriel Virella
Immunosuppression and immunomodulation.
Immunology series 1993;58():465-80.
1993: J M Goust; G Tsokos; Gabriel Virella
Tolerance and autoimmunity.
Immunology series 1993;58():397-421.
1993: Gabriel Virella
Immune complex diseases.
Immunology series 1993;58():379-96.
1993: Gabriel Virella; M A Spivey
Immunohematology.
Immunology series 1993;58():361-78.
1993: Gabriel Virella
Hypersensitivity reactions.
Immunology series 1993;58():329-41.
1993: Gabriel Virella
Diagnostic evaluation of phagocytic function.
Immunology series 1993;58():311-27.
1993: Gabriel Virella; C Patrick; J M Goust
Diagnostic evaluation of lymphocyte functions and cell-mediated immunity.
Immunology series 1993;58():291-310.
1993: Gabriel Virella
Diagnostic evaluation of humoral immunity.
Immunology series 1993;58():275-89.
1993: Gabriel Virella
Diagnostic immunology.
Immunology series 1993;58():251-73.
1993: Gabriel Virella
Infections and immunity.
Immunology series 1993;58():233-50.
1993: Gabriel Virella
The humoral immune response and its induction by active immunization.
Immunology series 1993;58():213-32.
1993: Gabriel Virella
Antigen-antibody reactions.
Immunology series 1993;58():117-33.
1993: Gabriel Virella
Introduction to medical immunology.
Immunology series 1993;58():1-8.
1993: Gabriel Virella
Antigenicity and immune recognition.
Immunology series 1993;58():49-74.
1992: Maria F Lopes-Virella; Gabriel Virella
Immune mechanisms of atherosclerosis in diabetes mellitus.
Diabetes 1992;41 Suppl 2():86-91.
1992: Maria F Lopes-Virella; Gabriel Virella
Lipoproteins and immune responses in the vascular wall and their contribution to atherosclerosis in diabetes.
Metabolism: clinical and experimental 1992;41(5 Suppl 1):11-5.
1991: Gabriel Virella; K Fourspring; B Hyman; R Haskill-Stroud; L Long; Isabel Virella-Lowell; M La Via; A J Gross; Maria F Lopes-Virella
Immunosuppressive effects of fish oil in normal human volunteers: correlation with the in vitro effects of eicosapentanoic acid on human lymphocytes.
Clinical immunology and immunopathology 1991;61(2 Pt 1):161-76.
1991: Maria F Lopes-Virella; R L Griffith; K A Shunk; Gabriel Virella
Enhanced uptake and impaired intracellular metabolism of low density lipoprotein complexed with anti-low density lipoprotein antibodies.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1991;11(5):1356-67.
1991: C Gisinger; Gabriel Virella; Maria F Lopes-Virella
Erythrocyte-bound low-density lipoprotein immune complexes lead to cholesteryl ester accumulation in human monocyte-derived macrophages.
Clinical immunology and immunopathology 1991;59(1):37-52.
1991: Gabriel Virella; B Hyman
Quantitation of anti-tetanus and anti-diphtheria antibodies by enzymoimmunoassay: methodology and applications.
Journal of clinical laboratory analysis 1991;5(1):43-8.
1991: Maria F Lopes-Virella; Gabriel Virella
Immune mechanisms in the pathogenesis of atherosclerosis.
Advances in experimental medicine and biology 1991;285():383-92.
1990: Gabriel Virella; T Thompson; R Haskill-Strowd
A new quantitative nitroblue tetrazolium reduction assay based on kinetic colorimetry.
Journal of clinical laboratory analysis 1990;4(2):86-9.
1990: C C Patrick; J M Goust; Gabriel Virella
Tolerance and autoimmunity.
Immunology series 1990;50():415-33.
1990: Gabriel Virella
Immune complex diseases.
Immunology series 1990;50():395-414.
1990: Gabriel Virella
Hypersensitivity reactions.
Immunology series 1990;50():341-55.
1990: Gabriel Virella; C C Patrick; J M Goust
Diagnostic evaluation of cell-mediated immunity.
Immunology series 1990;50():303-21.
1990: Gabriel Virella
Humoral immune response.
Immunology series 1990;50():217-37.
1990: Gabriel Virella
Biosynthesis, metabolism, and biological properties of immunoglobulins.
Immunology series 1990;50():93-105.
1990: Gabriel Virella
Immunoglobulin structure.
Immunology series 1990;50():77-92.
1990: Gabriel Virella; H H Fudenberg
Immunodeficiency diseases.
Immunology series 1990;50():565-92.
1990: Gabriel Virella; J M Goust
Malignancies of the immune system.
Immunology series 1990;50():535-63.
1990: Gabriel Virella
Antigenicity and immune recognition.
Immunology series 1990;50():53-76.
1990: D S Machado; Gabriel Virella
Transplantation immunology.
Immunology series 1990;50():499-512.
1990: J M Goust; H C Stevenson; R M Galbraith; Gabriel Virella
Immunosuppression and immunomodulation.
Immunology series 1990;50():481-98.
1990: Gabriel Virella; M A Spivey
Immunohematology.
Immunology series 1990;50():375-94.
1990: Gabriel Virella
Diagnostic evaluation of phagocytic function.
Immunology series 1990;50():323-40.
1990: Gabriel Virella
Diagnostic evaluation of humoral immunity.
Immunology series 1990;50():285-302.
1990: Gabriel Virella
Immunoserology and diagnostic immunochemistry.
Immunology series 1990;50():259-84.
1990: Gabriel Virella
Immunological aspects of the host-parasite relationship.
Immunology series 1990;50():239-57.
1990: Gabriel Virella
Antigen-antibody reactions.
Immunology series 1990;50():123-41.
1990: Gabriel Virella; C C Patrick; J M Goust
Tissues and cells in the immune response.
Immunology series 1990;50():11-30.
1990: Gabriel Virella
Medical immunology. Introduction.
Immunology series 1990;50():1-9.
1990: R Trifiletti; B Hyman; M LaVia; W Knapp; Gabriel Virella
The stimulation of T cells with anti-CD2 monoclonal antibodies facilitates the induction of polyclonal B-cell responses but does not enhance the activation of antigen-specific B cells.
Scandinavian journal of immunology 1990;31(1):25-31.
1989: R Trifiletti; M La Via; Gabriel Virella
The potentiation of B lymphocyte responses through CD2/LFA-3 interactions involving erythrocytes is IL2 independent.
Cellular immunology 1989;124(2):359-67.
1989: Gabriel Virella
[Red cells and the immune system].
Sangre 1989;34(5):355-64.
1989: M Vaughn; Gabriel Virella; Maria F Lopes-Virella
Diabetes, autoimmunity, and arteriosclerosis.
Clinical immunology and immunopathology 1989;52(3):414-20.
1989: Gabriel Virella; J M Kilpatrick; M T Rugeles; B Hyman; R Russell
Depression of humoral responses and phagocytic functions in vivo and in vitro by fish oil and eicosapentanoic acid.
Clinical immunology and immunopathology 1989;52(2):257-70.
1988: Gabriel Virella; M T Rugeles; B Hyman; M La Via; J M Goust; M Frankis; B E Bierer
The interaction of CD2 with its LFA-3 ligand expressed by autologous erythrocytes results in enhancement of B cell responses.
Cellular immunology 1988;116(2):308-19.
1988: R L Griffith; Gabriel Virella; H C Stevenson; Maria F Lopes-Virella
Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation.
The Journal of experimental medicine 1988;168(3):1041-59.
1988: A Gabrielli; Richard M Silver; G Teti; M S Chiofalo; A Misefari; D Venza-Teti; Gabriel Virella; M F La Via
Mononuclear cells from rheumatoid arthritis patients exhibit a depressed IgM response to sheep erythrocyte stimulation in vitro.
Diagnostic and clinical immunology 1988;5(5):266-8.
1988: A Gabrielli; Richard M Silver; G Teti; M S Chiofalo; A Misefari; D Venza-Teti; Gabriel Virella; M F La Via
Depression by Fc gamma receptor ligands of SRBC-induced IgM-PFC generation in human blood mononuclear cell cultures.
Diagnostic and clinical immunology 1988;5(6):304-8.
1987: J M Kilpatrick; B Hyman; Gabriel Virella
Human endothelial cell damage induced by interactions between polymorphonuclear leukocytes and immune complex-coated erythrocytes.
Clinical immunology and immunopathology 1987;44(3):335-47.
1987: Y K Chou; W Stanley; Gabriel Virella; J M Kilpatrick; H H Fudenberg
Generation of phenotypically distinct macrophage-hepatoma hybrid clones.
Immunobiology 1987;174(4-5):444-59.
1987: Gabriel Virella; Maria F Lopes-Virella
Infections and atherosclerosis.
Transplantation proceedings 1987;19(4 Suppl 5):26-35.
1987: M T Rugeles; M La Via; J M Goust; J M Kilpatrick; B Hyman; Gabriel Virella
Autologous red blood cells potentiate antibody synthesis by unfractionated human mononuclear cell cultures.
Scandinavian journal of immunology 1987;26(2):119-27.
1987: J M Kilpatrick; A Pitt; S Allen; S K Ainsworth; R J Castriotta; Gabriel Virella
Treatment of acute serum sickness by plasma ultrafiltration.
The American journal of the medical sciences 1987;293(2):75-84.
1986: T A Sherwood; Gabriel Virella
The binding of immune complexes to human red cells: complement requirements and fate of the RBC-bound IC after interaction with human phagocytic cells.
Clinical and experimental immunology 1986;64(1):195-204.
1986: Gabriel Virella; A B Glassman
Apheresis, exchange, adsorption and filtration of plasma: four approaches to the removal of undesirable circulating substances.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1986;40(8):286-96.
1986: Gene E. Burges; H P Holley; Gabriel Virella
Immunoglobulin class of anti-Candida antibodies in patients with vaginal candidiasis.
Diagnostic immunology 1986;4(1):43-6.
1985: Maria F Lopes-Virella; Gabriel Virella
Immunological and microbiological factors in the pathogenesis of atherosclerosis.
Clinical immunology and immunopathology 1985;37(3):377-86.
1985: J M Kilpatrick; Gabriel Virella
Inhibition of platelet-activating factor by rabbit C-reactive protein.
Clinical immunology and immunopathology 1985;37(2):276-81.
1985: J M Kilpatrick; A Pitt; S K Ainsworth; Gabriel Virella
Validation of the PEG-IgG screening test for soluble immune complexes by longitudinal studies in experimental acute serum sickness.
Journal of clinical & laboratory immunology 1985;17(2):79-84.
1985: Y K Chou; T Sherwood; Gabriel Virella
Erythrocyte-bound immune complexes trigger the release of interleukin-1 from human monocytes.
Cellular immunology 1985;91(1):308-14.
1985: L Bonewald; Gabriel Virella; A C Wang
Evidence for the biclonal nature of a Waldenstrom's macroglobulinemia.
Clinica chimica acta; international journal of clinical chemistry 1985;146(1):53-63.
1985: Gabriel Virella; B Hyman; J M Kilpatrick
Solid-phase enzymoimmunoassay of antitetanus toxoid antibodies.
Diagnostic immunology 1985;3(4):215-9.
1984: B Battersby; T Sherwood; P Winocour; Gabriel Virella
Human platelets aggregate during antigen-antibody reactions at different antigen-antibody ratios.
Journal of clinical & laboratory immunology 1984;15(2):57-61.
1984: Z Y Chen; Gabriel Virella; H E Tung; S K Ainsworth; Richard M Silver; A C Wang; M F LaVia; Hildegard R Maricq; Richard L. Dobson
Immune complexes and antinuclear, antinucleolar, and anticentromere antibodies in scleroderma.
Journal of the American Academy of Dermatology 1984;11(3):461-7.
1984: S Sager; Gabriel Virella; W Y Chen; H H Fudenberg
Isolation and characterization of an outer membrane protein of Salmonella paratyphi B: a mitogen and polyclonal activator of human B lymphocytes.
Immunology 1984;52(1):67-78.
1983: Gabriel Virella; C W Shuler; T Sherwood
Non-complement-dependent adsorption of soluble immune complexes to human red cells.
Clinical and experimental immunology 1983;54(2):448-54.
1983: Gabriel Virella; Maria F Lopes-Virella; C Shuler; T Sherwood; G A Espinoza; P Winocour; John A Colwell
Release of PAF by human polymorphonuclear leucocytes stimulated by immune complexes bound to Sepharose particles and human erythrocytes.
Immunology 1983;50(1):43-51.
1983: Gene E. Burges; H P Holley; Gabriel Virella
Circulating immune complexes in patients with Candida albicans infections.
Clinical and experimental immunology 1983;53(1):165-74.
1983: Gene E. Burges; H P Holley; N M Burdash; Gabriel Virella
Immunological diagnosis of systemic candidiasis by counterimmunoelectrophoresis and quantitative immunofluorescence using purified antigens.
Diagnostic immunology 1983;1(4):295-302.
1983: J M Kilpatrick; Gabriel Virella
Statistical analysis of five immune complex screening assays: patterns of detection in patients with rheumatoid arthritis, systemic lupus erythematosus, infectious endocarditis, and diabetes mellitus.
Diagnostic immunology 1983;1(2):57-63.
1982: Gabriel Virella; A Espinoza; H Patrick; John A Colwell
Polymorphonuclear leucocytes release a factor(s) that induces platelet aggregation and ATP release after interaction with insoluble and surface-fixed immune complexes.
Clinical and experimental immunology 1982;49(3):684-94.
1982: J M Kilpatrick; Gabriel Virella
The role of circulating immune complexes in the pathogenesis of diabetes mellitus.
Acta diabetologica latina 1982;19(2):107-39.
1982: J M Kilpatrick; Gabriel Virella
Development of a single numerical expression for the results of multiple screening tests for immune complexes in diabetic patients: use in statistical comparison of clinically and biochemically defined patient populations.
Journal of clinical & laboratory immunology 1982;7(3):163-6.
1981: Gabriel Virella; H Wohltmann; Julius Sagel; Maria F Lopes-Virella; M Kilpatrick; C Phillips; John A Colwell
Soluble immune complexes in patients with diabetes mellitus: detection and pathological significance.
Diabetologia 1981;21(3):184-91.
1981: J Van Zile; M Kilpatrick; M Laimins; Julius Sagel; John A Colwell; Gabriel Virella
Platelet aggregation and release of ATP after incubation with soluble immune complexes purified from the serum of diabetic patients.
Diabetes 1981;30(7):575-9.
1981: W Y Chen; J Muñoz; H H Fudenberg; E Tung; Gabriel Virella
Polyclonal activation of human peripheral blood B lymphocytes by formaldehyde-fixed Salmonella paratyphi B. I. Immunoglobulin production without DNA synthesis.
The Journal of experimental medicine 1981;153(2):365-74.
1981: Gabriel Virella; J M Kilpatrick; F Chenais; H H Fudenberg
Isolation of soluble immune complexes from human serum: combined use of polyethylene glycol precipitation, gel filtration, and affinity chromatography on protein A-Sepharose.
Methods in enzymology 1981;74 Pt C():644-63.
1981: John A Colwell; J Van Zile; J M Kilpatrick; R M Nair; Gabriel Virella
Plasma factors and platelet aggregation in diabetes mellitus.
Hormone and metabolic research. Supplement series 1981;11():1-6.
1981: J Muñoz; Gabriel Virella; H H Fudenberg
Immunonephelometric assay for immunoglobulins released by cultured lymphocytes.
Methods in enzymology 1981;73(Pt B):578-96.
1980: M D Pavy; P L Murphy; Gabriel Virella
Paraprotein-induced hyperviscosity. A reversible cause of stroke.
Postgraduate medicine 1980;68(3):109-12.
1980: M Munoz; G Estes; M Kilpatrick; A Di Salvo; Gabriel Virella
Purification of cytoplasmic antigens from the mycelial phase of Candida albicans: possible advantages of its use in Candida serology.
Mycopathologia 1980;72(1):47-53.
1980: Gabriel Virella; D Russell; M Laimins; John A Colwell
Simplified method for detecting anti-insulin antibodies and insulin-anti-insulin immune complexes.
Clinical chemistry 1980;26(9):1357-9.
1980: Maria F Lopes-Virella; Gabriel Virella; G Evans; S B Malenkos; John A Colwell
Immunonephelometric assay of human apolipoprotein AI.
Clinical chemistry 1980;26(8):1205-8.
1980: J M Kilpatrick; Gabriel Virella
Isolation and characterization of soluble insulin-anti-insulin immune complexes formed in vitro and in vivo in sera from patients with diabetes mellitus.
Clinical and experimental immunology 1980;40(3):445-52.
1980: C C Patrick; Gabriel Virella; H H Fudenberg
Experimental model of chronic serum sickness. Relationships between proteinuria, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and glomerular and extraglomerular renal pathology.
Archives of pathology & laboratory medicine 1980;104(6):293-9.
1980: J Pryjma; J Muñoz; Gabriel Virella; H H Fudenberg
Evaluation of IgM, IgG, IgA, IgD, and IgE secretion by human peripheral blood lymphocytes in cultures stimulated with pokeweed mitogen and Staphylococcus aureus Cowan I.
Cellular immunology 1980;50(1):115-24.
1980: Gabriel Virella
Screening for polymeric IgM: some overlooked history.
Clinical chemistry 1980;26(3):533-4.
1980: J P Salier; C Rivat; L Rivat; C Bastard; Gabriel Virella; H H Fudenberg; A C Wang
Quantitative studies of Gm allotypes--IV. Quantitative variation of G1m(3) antigenicity in relation to light chain type and Vk sub-group.
Molecular immunology 1980;17(2):229-35.
1980: J Pryjma; J Muñoz; R M Galbraith; H H Fudenberg; Gabriel Virella
Induction and suppression of immunoglobulin synthesis in cultures of human lymphocytes: effects of pokeweed mitogen and Staphylococcus aureus Cowan I.
Journal of immunology (Baltimore, Md. : 1950) 1980;124(2):656-61.
1980: J Muñoz; Gabriel Virella; M P Arala-Chaves; H H Fudenberg
Measurements of extracellular immunoglobulins as an index of B cell function.
Haematologia 1980;13(1-4):213-23.
1980: G B Estes; M Muñoz; N M Burdash; Gabriel Virella
A quantitative immunofluorescence test for the detection of anti-Candida antibodies.
Journal of immunological methods 1980;35(1-2):105-13.
1980: H H Fudenberg; Gabriel Virella
Multiple myeloma and Waldenström macroglobulinemia: unusual presentations.
Seminars in hematology 1980;17(1):63-79.
1980: J Munoz; J Pryjma; H H Fudenberg; Gabriel Virella
Immunoglobulin quantitation and enumeration of immunoglobulin-producing cells: comparison of two index of B-cell activation.
Scandinavian journal of immunology 1980;12(4):345-53.
1979: S H Sandifer; R T Wilkins; N H Whitlock; Gabriel Virella; C B Loadholt; T C Leitner
Urinary protein excretion in workers exposed to low doses of cadmium.
Bulletin of environmental contamination and toxicology 1979;23(1-2):129-35.
1979: Gabriel Virella; H H Fudenberg
Twenty-fifth annual national meeting of the reticuloendothelial society.
Clinical immunology and immunopathology 1979;14(1):137-42.
1979: Maria F Lopes-Virella; Gabriel Virella; M Debeukelaer; C J Owens; John A Colwell
Urinary high density lipoprotein in minimal change glomerular disease and chronic glomerulopathies.
Clinica chimica acta; international journal of clinical chemistry 1979;94(1):73-81.
1979: C C Patrick; Gabriel Virella; J F McManus; W P Faulk; H D Hughson; H H Fudenberg
Induction of extraglomerular renal damage in experimental chronic serum sickness. I. Histologic and immunofluorescence findings.
Laboratory investigation; a journal of technical methods and pathology 1979;40(5):603-14.
1979: Maria F Lopes-Virella; Gabriel Virella; G Rosebrock; Julius Sagel; J Gonzalez; J Colwell
Early diagnosis of renal malfunction in diabetics. Abnormal proteinuria revealed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Diabetologia 1979;16(3):165-71.
1979: Gabriel Virella; J Muñoz; J E Robinson; J M Goust
Assay of immunoglobulins in supernatants of lymphoid cell lines by conventional laser nephelometry.
Zeitschrift für Immunitätsforschung. Immunobiology 1979;155(4):279-86.
1979: Gabriel Virella; J Munoz; Maria F Lopes-Virella; B Ward; R Gadsden
Rapid immunochemical determination of free hemoglobin in plasma and urine with a laser nephelometer.
Clinical chemistry 1979;25(3):497-9.
1979: Janardan P Pandey; H H Fudenberg; Gabriel Virella; C U Kyong; C B Loadholt; R M Galbraith; E C Gotschlich; J C Parke
Association between immunoglobulin allotypes and immune responses to Haemophilus influenzae and Meningococcus polysaccharides.
Lancet 1979;1(8109):190-2.
1979: Gabriel Virella; W A Hipp; J F John; B Kahaleh; M Ford; H H Fudenberg
Nephelometric detection of soluble immune complexes: methodology and clinical applications.
International archives of allergy and applied immunology 1979;58(4):402-10.
1979: J Goudswaard; Gabriel Virella; A Noordzij
Difference in hydrophobicity of human and animal IgA.
Comparative immunology, microbiology and infectious diseases 1979;1(3):163-8.
1978: C U Kyong; Gabriel Virella; H H Fudenberg; Charles Pinckney Darby
X-linked immunodeficiency with increased IgM: clinical, ethnic, and immunologic heterogeneity.
Pediatric research 1978;12(10):1024-6.
1978: Gabriel Virella; H H Fudenberg; K U Kyong; Janardan P Pandey; R M Galbraith
A practical method for quantitation of antibody responses to tetanus and diphtheria toxoids in normal young children.
Zeitschrift für Immunitätsforschung. Immunobiology 1978;155(1):80-6.
1978: Gabriel Virella; J Goudswaard; Robert J Boackle
Preparation of saliva samples for immunochemical determinations of immunoglobulins and for assay of lysozyme.
Clinical chemistry 1978;24(8):1421-2.
1978: Gabriel Virella; J Koistinen; R Cardenas; C C Patrick; Thomas B. Higerd; J W Fett; H H Fudenberg
Differential sensitivity of IgA proteins of different subclasses and allotypes to reduction of disulfide bonds and digestion by streptococcal protease.
Immunochemistry 1978;15(3):165-70.
1978: Gabriel Virella; W A Hipp; W Hood
Effect of antibody binding on the mobility of serum lysozyme.
Clinical chemistry 1978;24(3):514-5.
1978: C C Patrick; Gabriel Virella
Isolation of normal human IgG3. Identical molecular weight for normal and monoclonal gamma-3 chains.
Immunochemistry 1978;15(2):137-9.
1978: Gabriel Virella; J Goudswaard
Measurement of salivary lysozyme.
Journal of dental research 1978;57(2):326-8.
1978: Gabriel Virella; M Waller; H H Fudenberg
Nephelometric method for determination of rheumatoid factor.
Journal of immunological methods 1978;22(3-4):247-51.
1978: J Goudsward; Gabriel Virella
Use of laser nephelometry to measure dog lysozyme: immunological cross-reactivity with human lysozyme.
Research in veterinary science 1978;24(1):119-21.
1978: J Goudswaard; Gabriel Virella
New immunofluorescent antibody test for diagnosis of candidiasis using macrophages-engulfed antigens as substrate.
Journal of immunological methods 1978;20():357-63.
1978: Gabriel Virella; Paul C Montgomery; I M Lemaitre-Coelho
Transport of oligomeric IgA of systemic origin into external secretions.
Advances in experimental medicine and biology 1978;107():241-51.
1978: Gabriel Virella; Maria F Lopes-Virella; J Levine; M Ogawa; J Gonzalez
"Idiopathic" Bence-Jones proteinuria.
Acta haematologica 1978;60(5):269-79.
1977: C C Patrick; Gabriel Virella; J Koistinen; H H Fudenberg
Differential binding of IgA proteins of different subclasses and allotypes to Staphylococcal protein A.
Zeitschrift für Immunitätsforschung. Immunobiology 1977;153(5):466-9.
1977: Gabriel Virella; H H Fundenberg
Comparison of immunoglobulin determinations in pathological sera by radial immunodiffusion and laser nephelometry.
Clinical chemistry 1977;23(10):1925-8.
1977: Gabriel Virella; C J Yeh
The sensitivity to plasmin digestion of human IgG proteins of different heavy chain subclasses.
Experientia 1977;33(9):1231-3.
1977: S Mathur; J Koistinen; C U Kyong; E O Horger; Gabriel Virella; H H Fudenberg
Antibodies to Candida albicans in IgA-deficient humans.
The Journal of infectious diseases 1977;136(3):436-8.
1977: Gabriel Virella; J Goudswaard; F W Tischendorf; H H Fudenberg
Urinary lysozyme phenotypes in monocytic leukemia.
Clinica chimica acta; international journal of clinical chemistry 1977;79(2):503-6.
1977: Gabriel Virella; Maria F Lopes-Virella
New approaches to the study of proteinuria.
Clinical chemistry 1977;23(9):1793-4.
1977: J Goudswaard; Gabriel Virella
Immunochemical determination of human lysozyme by laser nephelometry.
Clinical chemistry 1977;23(6):967-70.
1977: Y Yamamura; Gabriel Virella; Stephen J Haskill
Immunologic responses to a murine mammary adenocarcinoma. I. Passive transfer of immunity by sera from tumor-bearing mice.
International journal of cancer. Journal international du cancer 1977;19(5):707-16.
1977: Gabriel Virella; J M Monteiro; Maria F Lopes-Virella; A Ducla Soares; H H Fudenberg
Asynchronous development of two monoclonal proteins (IgM lambda and delta 1 chains) in a patient with abdominal lymphoma.
Cancer 1977;39(5):2247-53.
1977: S S Spicer; R Frayser; Gabriel Virella; B J Hall
Immunocytochemical localization of lysozymes in respiratory and other tissues.
Laboratory investigation; a journal of technical methods and pathology 1977;36(3):282-95.
1977: Gabriel Virella
Electrophoresis of lysozyme into Microscoccus-containing agarose gel: quantitative and analytical applications.
Clinica chimica acta; international journal of clinical chemistry 1977;75(1):107-15.
1977: F Chenais; Gabriel Virella; C C Patrick; H H Fudenberg
Isolation of soluble immune complexes by affinity chromatography using staphylococcal protein A--Sepharose as substrate.
Journal of immunological methods 1977;18(1-2):183-92.
1977: Paul C Montgomery; S A Khaleel; J Goudswaard; Gabriel Virella
Selective transport of an oligomeric IgA into canine saliva.
Immunological communications 1977;6(6):633-42.
1977: Thomas B. Higerd; Gabriel Virella; R Cardenas; J Koistinen; J W Fett
New method for obtaining IgA-specific protease.
Journal of immunological methods 1977;18(3-4):245-9.
1977: Gabriel Virella; R J Slappendel; J Goudswaard
Multiple myeloma, IgA cryoglobulinemia and serum hyperviscosity in a dog.
International archives of allergy and applied immunology 1977;55(1-6):537-41.
1977: F Chenais; Gabriel Virella; C D Young; P Liu; T S Whittle
Atypical B cell dyscrasia with Bence-Jones proteinuria and intracellular retention of gamma-chains.
Acta haematologica 1977;58(3):166-72.
1976: Gabriel Virella; H H Fudenberg
Primary care.
Journal of medical education 1976;51(11):955-6.
1976: Maria F Lopes-Virella; K Sarji; Gabriel Virella; John A Colwell
Platelet lipoproteins. A comparative study with serum lipoproteins.
Biochimica et biophysica acta 1976;439(2):339-48.
1976: Gabriel Virella; H H Fudenberg
Letter: Light-chain nephropathy.
The New England journal of medicine 1976;294(18):1007-8.
1976: Gabriel Virella; M C Lechner
Two IgM paraproteins differing in carbohydrate content in a patient with Waldenström's macroglobulinemia.
Clinica chimica acta; international journal of clinical chemistry 1976;67(2):137-44.
1975: Gabriel Virella
The electrophoretic mobility of serum lysozyme.
Experientia 1975;31(12):1465-7.
1975: Gabriel Virella; R V Preto; F Graça
Polymerized monoclonal IgA in tuo patients with myelomatosis and hyperviscosity syndrome.
British journal of haematology 1975;30(4):479-87.
1975: M T Pires; A S Da Cunha; Gabriel Virella; J Simões
Analytical characterization of urinary proteins by sodium dodecyl sulphate-polyacrylamide gel electrophoresis in renal disease. Clinical and histopathological correlations.
Nephron 1975;14(5):361-72.
1975: Gabriel Virella; J J Da Silva; M F Lópes-Virella; F Parreira
[Intracellular dight chains in peripheral lymphocytes of a patient with chronic lymphatic leukemia and lambda Bence-Jones proteinuria (author's transl)].
Sangre 1975;20(4):456-66.
1974: R Adolfo Coelho; Gabriel Virella; V Hugo Soares; A Filipe da Cunha; R Valadas Preto
[Hypergammaglobulinemic purpura associated to interstitial nephropathy with functional tubular defect].
Revista clínica española 1974;135(2):181-7.
1974: I M Coelho; M T Pereira; Gabriel Virella; R A Thompson
Salivary immunoglobulins in a patient with IgA deficiency.
Clinical and experimental immunology 1974;17(4):685-9.
1974: I M Coelho; M T Pereira; Gabriel Virella
Analytical study of salivary immunoglobulins in multiple myeloma.
Clinical and experimental immunology 1974;17(3):417-26.
1974: L Lopes-Virella; Gabriel Virella; F Parreira; S Sequerra-Amram
[Comparative analysis of various technics for the separation of serum lipoproteins].
Revista clínica española 1974;133(3):195-204.
1974: Gabriel Virella; I M Coelho
Unexpected mobility of human lambda chains in sodium dodecyl sulphate-polyacrylamide gel electrophoresis.
Immunochemistry 1974;11(3):157-60.
1974: Gabriel Virella; M T Pires; I M Coelho
Analytical characterization of the urinary proteins from sixty patients with monoclonal gammopathies.
Clinica chimica acta; international journal of clinical chemistry 1974;50(1):63-75.
1974: M J Metrass; Gabriel Virella; M A Baptista-Cunha; G Afonso
[Alpha chain-producing intestinal lymphoma (author's transl)].
Sangre 1974;19(4):418-34.
1973: Gabriel Virella
Preparative block electrophoresis using Sephadex G-25.
Experientia 1973;29(4):502-4.
1973: Gabriel Virella; R M Parkhouse
Sensitivity to reduction of human immunoglobulin G of different heavy chain sub-classes.
Immunochemistry 1973;10(4):213-7.
1973: Gabriel Virella; M M de Freitas
Structural characterization of immunoglobulins contained in polyacrylamide gels.
Experientia 1973;29(2):142-4.
1972: Gabriel Virella; R M Parkhouse
Determination of the molecular weight of human gamma-3 chains by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulphate.
Immunology 1972;23(6):857-60.
1972: J J Cream; A Howard; Gabriel Virella
IgG heavy chain sub-classes in mixed cryoglobulins.
Immunology 1972;23(3):405-11.
1972: Gabriel Virella; M A Silveira Nunes; G Tamagnini
Placental transfer of human IgG subclasses.
Clinical and experimental immunology 1972;10(3):475-8.
1972: Gabriel Virella; I Marqués Coelho; F Parreira
[Immunochemical characterization of intracellular proteins of the bone marrow in cases of monoclonal gammapathy and polyclonal hypergammaglobulinemia].
Sangre 1972;17(4):457-66.
1972: Gabriel Virella
[IgG: an important structural subclass of human G immunoglobulin].
Sangre 1972;17(3):283-92.
1971: Gabriel Virella; J R Hobbs
Heavy chain typing in IgG monoclonal gammopathies with special reference to cases of serum hyperviscosity and cryoglobulinaemia.
Clinical and experimental immunology 1971;8(6):973-80.
1971: Gabriel Virella
IgG subclasses in relation to viscosity and cryoglobulin syndromes.
British medical journal 1971;2(5757):322.
1971: Gabriel Virella; R M Parkhouse
Detection of monomeric IgM by acrylamide disc gel electrophoresis followed by agar gel immunodiffusion.
Clinica chimica acta; international journal of clinical chemistry 1971;32(3):427-31.
1971: R M Parkhouse; Gabriel Virella; R R Dourmashkin
Structural characterization of a human monoclonal IgA protein.
Clinical and experimental immunology 1971;8(4):581-91.
1971: Gabriel Virella; A De Pascale; U Lippi
Placental transfer of a human IgG2 monocional protein.
Experientia 1971;27(3):324-5.
1971: Gabriel Virella; R M Parkhouse
Papain sensitivity of heavy chain sub-classes in normal human IgG and localizaton of antigenic determinants for the sub-classes.
Immunochemistry 1971;8(3):243-50.
1971: R R Dourmashkin; Gabriel Virella; R M Parkhouse
Electron microscopy of human and mouse myeloma serum IgA.
Journal of molecular biology 1971;56(1):207-8.
1971: Gabriel Virella
Degradation of IgG3 monoclonal proteins during storage and in the presence of a thiol (DL-penicillamine).
Experientia 1971;27(1):94-6.
1971: Gabriel Virella
[Relations between human IgG subclasses, hyperviscosity and cryoprecipitation].
Sangre 1971;16(4):329-36.
1970: Gabriel Virella; A Howard; J Cherrington
Distribution of heavy chain sub-classes of immunoglobulin G in normal IgG and residual IgG from hypogamma-globulinaemic sera.
Clinical and experimental immunology 1970;7(5):671-80.
1970: Gabriel Virella; A Howard
Correlation between electrophoretic mobility and heavy chain sub-classes of residual IgG from patients with severe hypogammaglobulinaemia.
Experientia 1970;26(8):901-3.
1970: Gabriel Virella; Maria F Lopes-Virella
Effects of therapeutically useful thiols (DL-penicillamine and alpha-mercaptopropionylglycine) on immunoglobulins.
Clinical and experimental immunology 1970;7(1):85-107.
1969: Gabriel Virella
Demonstration of molecular size differences between closely related antigens by a simple gel diffusion tes.
Experientia 1969;25(11):1175-7.
1969: Gabriel Virella
[Studies on the use of the rivanol test for the identification of macroglobulinemia].
Sangre 1969;14(4):463-70.
1969: Gabriel Virella
[Study on the usefulness of the penicillamine test for the diagnosis of macroglobulinemias].
Sangre 1969;14(2):183-94.